This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International Europe

BPI Europe is in

  • 00
  • 00
  • 00
  • 00
Attend Our Upcoming Hybrid Event held 17-20 May 2022!
Messe Wien Congress CentreVienna

Bernd Voedisch
Lab Head R & D at Novartis


Dr. Bernd Voedisch studied Biotechnology at Braunschweig University of Technology in Braunschweig, Germany. He did his PhD in the field of recombinant antibody technologies and then joined the Novartis Institutes for Biomedical Research (NIBR) in Basel, Switzerland, as a PostDoc. He stayed at Novartis as a lab head in the Biologics protein production platform, providing project teams with proteins and recombinant cell lines enabling discovery and characterization of various therapeutic protein classes (i.e., antibodies, multi-specifics, and non-antibody therapeutic proteins). He then switched to the cell line development unit where his additional responsibilities include the early assessment of Biologics candidates in the CHO expression system and generation of monoclonal CHO cell lines for Biologics manufacturing for clinical and market supply.

Agenda Sessions

  • Chairperson's Opening Remarks

  • Chairperson's Remarks

  • Cell Line Development for Biologics R&D